Andrew Shao
Andrew Shao serves as the senior vice-president of global regulatory and scientific affairs at Niagen Bioscience, a company that specializes in NAD+ supplements. He recently responded to new research on NAD+ levels, emphasizing that while the findings may shift perceptions, they do not fundamentally change the importance of understanding NAD+ dynamics in tissue, particularly in the context of consumer health and wellness.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| New Zealand | 1 | 5.00 | 1.11% | +0% | 4,822,233 | 53,580 | $210,000 | 2,333$ |
| Totals | 1 | 4,822,233 | 53,580 | $210,000 | 2,333$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
New Zealand:
Andrew Shao is the senior vice-president of global regulatory and scientific affairs at Niagen Bioscience, which sells NAD+ supplements.
5